(firstQuint)Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain.

 The purpose of this study is to assess the effectiveness and tolerability of oxymorphone ER for the treatment of moderate to severe chronic pain in opioid-naive patients.

 Patients are gradually titrated from a 5mg dose of oxymorphone ER (taken every 12 hours) until stabilized dose is achieved.

 The study design is an open-label, nonrandomized 6-month study with a titration/stabilization period of 1 month followed by a 5-month maintenance period.

.

 Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain@highlight

The purpose of this study is to determine if oxymorphone ER is effective and safe in treating chronic pain in opioid-naive patients.

